Evidence map›Paper›PMID 31296858›Full record

ArticleNature communications2019

Practical access to axially chiral sulfonamides and biaryl amino phenols via organocatalytic atroposelective N-alkylation.

Shenci Lu, Shawn Voon Hwee Ng, Kaitlyn Lovato, Jun-Yang Ong, Si Bei Poh, Xiao Qian Ng, László Kürti, Yu Zhao

Abstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Recent advances in organocatalytic atroposelective reactions.Beilstein journal of organic chemistry · 2025
    Review
  4. Article
  5. Atroposelective catalysis.Nature reviews. Chemistry · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Atroposelective synthesis ofChemical science · 2021
    Article
  16. Article
  17. Atropisomeric Properties ofThe Journal of organic chemistry · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shenci LuShaanxi Institute of Flexible Electronics, Northwestern Polytechnical University, Xi'an, 710072, China.ORCID http://orcid.org/0000-0003-4357-455X
Shawn Voon Hwee NgDepartment of Chemistry, National University of Singapore, 3 Science Drive 3, Singapore, 117543, Singapore.ORCID http://orcid.org/0000-0002-9679-4057
Kaitlyn LovatoDepartment of Chemistry, Rice University BioScience Research Collaborative, 6500 Main Street, Rm 380, Houston, TX, 77030, USA.ORCID http://orcid.org/0000-0002-7520-8362
Jun-Yang OngDepartment of Chemistry, National University of Singapore, 3 Science Drive 3, Singapore, 117543, Singapore.
Si Bei PohDepartment of Chemistry, National University of Singapore, 3 Science Drive 3, Singapore, 117543, Singapore.
Xiao Qian NgDepartment of Chemistry, National University of Singapore, 3 Science Drive 3, Singapore, 117543, Singapore.ORCID http://orcid.org/0000-0001-8597-4717
László KürtiDepartment of Chemistry, Rice University BioScience Research Collaborative, 6500 Main Street, Rm 380, Houston, TX, 77030, USA. kurti.laszlo@rice.edu.
Yu ZhaoDepartment of Chemistry, National University of Singapore, 3 Science Drive 3, Singapore, 117543, Singapore. zhaoyu@nus.edu.sg.ORCID http://orcid.org/0000-0002-2944-1315

Funding

A*STAR | Science and Engineering Research Council (Science and Engineering Research Council - A STAR) R-143-000-648-305
6 · The paper itself

Abstract

The importance of axial chirality in enantioselective synthesis has been widely recognized for decades. The practical access to certain structures such as biaryl amino phenols known as NOBINs in enantiopure form, however, still remains a challenge. In drug delivery, the incorporation of axially chiral molecules in systematic screening has also received a great deal of interest in recent years, which calls for innovation and practical synthesis of structurally different axially chiral entities. Herein we present an operationally simple catalytic N-alkylation of sulfonamides using commercially available chiral amine catalysts to deliver two important classes of axially chiral compounds: structurally diverse NOBIN analogs as well as axially chiral N-aryl sulfonamides in excellent enantiopurity. Structurally related chiral sulfonamide has shown great potential in drug molecules but enantioselective synthesis of them has never been accomplished before. The practical catalytic procedures of our methods also bode well for their wide application in enantioselective synthesis.

Indexed as

Drug Delivery SystemsAlkylationAminophenolsCatalysisChemistry, PharmaceuticalMolecular StructureStereoisomerismSulfonamidesAminophenolsSulfonamides

Identifiers

PMID31296858
PMCPMC6624369

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.